Chandan Healthcare (NSE:CHANDAN) Notes Receivable: ₹0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:CHANDAN Chandan Healthcare Ltd NSE:CHANDAN
17 GF Score
Price ₹231.10
! 4 Warning Signs
View Full Analysis

What is Chandan Healthcare Notes Receivable?

Chandan Healthcare NSE:CHANDAN -4.01% 17 Notes Receivable is ₹0 Mil as of Dec. 2025. GuruFocus rates NSE:CHANDAN with a GF Score™ of 17/100. The stock has 4 warning signs investors should review.

Chandan Healthcare's Notes Receivable for the quarter that ended in Dec. 2025 was ₹0 Mil.

Chandan Healthcare Notes Receivable Related Terms

Chandan Healthcare Notes Receivable Historical Data

* Premium members only.

The historical data trend for Chandan Healthcare's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chandan Healthcare Notes Receivable Chart

Chandan Healthcare Annual Data
Trend Mar22 Mar23 Mar24 Mar25
Notes Receivable
0.00 0.00 0.00 0.00

Chandan Healthcare Quarterly Data
Mar22 Mar23 Mar24 Dec24 Mar25 Sep25 Dec25
Notes Receivable Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
NSE:CHANDAN
17GF Score
Chandan Healthcare Ltd NSE:CHANDAN
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chandan Healthcare Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of ₹0 Mil mean?
Chandan Healthcare (NSE:CHANDAN) has a Notes Receivable of ₹0 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Chandan Healthcare and its competitors.
Is Chandan Healthcare's Notes Receivable too high?
Chandan Healthcare's current Notes Receivable is ₹0 Mil. Overall, Chandan Healthcare has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Chandan Healthcare's Notes Receivable compare to TMO and DHR?
Chandan Healthcare's Notes Receivable of ₹0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Medical Diagnostics & Research company?
A good Notes Receivable depends on the Medical Diagnostics & Research industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Chandan Healthcare and its competitors. Chandan Healthcare's current Notes Receivable is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chandan Healthcare stock overvalued right now?
Chandan Healthcare (NSE:CHANDAN) has a current Notes Receivable of ₹0 Mil. The current Notes Receivable is ₹0 Mil. Chandan Healthcare's overall GF Score™ is 17/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Chandan Healthcare (NSE:CHANDAN), the current Notes Receivable is ₹0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Chandan Healthcare Business Description

Address Kursi Road, Biotech Park, Sector G, Jankipuram, Lucknow, UP, IND, 226021
Chandan Healthcare Ltd operates laboratories that offer comprehensive pathological investigations. Its services encompass biochemistry, hematology, histopathology, microbiology, and immunology. Additionally, it provide an extensive array of radiology services, including CT scans, X-rays, and MRIs. The company operates single reportable business segment that is Diagnostics Services.
17GF Score

Get the complete analysis for NSE:CHANDAN

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹231.10
Price